{"id":"https://openalex.org/W1520508152","doi":"https://doi.org/10.1016/s1054-3589(08)57004-9","title":"Subtype-Selective GABAA Receptor Modulation Yields a Novel Pharmacological Profile: The Design and Development of TPA023","display_name":"Subtype-Selective GABAA Receptor Modulation Yields a Novel Pharmacological Profile: The Design and Development of TPA023","alternate_titles":[],"publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W1520508152","doi":"https://doi.org/10.1016/s1054-3589(08)57004-9","mag":"1520508152","pmid":"https://pubmed.ncbi.nlm.nih.gov/20230761"},"language":"en","primary_location":{"id":"doi:10.1016/s1054-3589(08)57004-9","doi":"https://doi.org/10.1016/s1054-3589(08)57004-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1054-3589(08)57004-9","pdf_url":null,"source":{"id":"https://openalex.org/S2764403048","display_name":"Advances in pharmacology","issn_l":"1054-3589","issn":["1054-3589","1557-8925"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacology","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W431361406","display_name":"Contemporary Aspects of Biomedical Research - Drug Discovery","relationship":"volume","link_type":"volume"}],"lineage":["https://openalex.org/W1520508152","https://openalex.org/W431361406"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021273","display_name":"John R. Atack","orcid":"https://orcid.org/0000-0002-3410-791X","observed_orcids":["https://orcid.org/0000-0002-3410-791X"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John R. Atack","raw_affiliation_strings":["Department of Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Turnhoutseweg 30, Beerse, B-2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, Turnhoutseweg 30, Beerse, B-2340, Belgium","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5027021273"],"corresponding_institution_ids":["https://openalex.org/I4405282460"],"apc_list":null,"apc_paid":null,"fwci":5.3271,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94857768,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"57","issue":null,"first_page":"137","last_page":"185"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.7760000228881836},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.8399999737739563},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.6660000085830688},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7580000162124634},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7160000205039978},{"id":"https://openalex.org/keywords/cyp3a-metabolism","display_name":"CYP3A metabolism","score":0.921999990940094},{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":0.7440000176429749},{"id":"https://openalex.org/keywords/controlled-release-formulation","display_name":"controlled-release formulation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7870000004768372},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.4309999942779541},{"id":"https://openalex.org/keywords/cognitive-performance","display_name":"cognitive performance","score":0.8379999995231628},{"id":"https://openalex.org/keywords/hamilton-anxiety-rating-scale","display_name":"Hamilton Anxiety Rating Scale","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C168258287","wikidata":"https://www.wikidata.org/wiki/Q60147","display_name":"GABAA receptor","level":3,"score":0.8387879729270935},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4907861649990082},{"id":"https://openalex.org/C123079801","wikidata":"https://www.wikidata.org/wiki/Q750240","display_name":"Modulation (music)","level":2,"score":0.48456087708473206},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41066649556159973},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4070783257484436},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.33826902508735657},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27038633823394775},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1266816258430481},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.12663307785987854},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s1054-3589(08)57004-9","doi":"https://doi.org/10.1016/s1054-3589(08)57004-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1054-3589(08)57004-9","pdf_url":null,"source":{"id":"https://openalex.org/S2764403048","display_name":"Advances in pharmacology","issn_l":"1054-3589","issn":["1054-3589","1557-8925"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Pharmacology","raw_type":"book-chapter"},{"id":"pmid:20230761","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20230761","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in pharmacology (San Diego, Calif.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":113,"referenced_works":["https://openalex.org/W64322893","https://openalex.org/W99900706","https://openalex.org/W1524203275","https://openalex.org/W1565551672","https://openalex.org/W1705744169","https://openalex.org/W1894940769","https://openalex.org/W1915393782","https://openalex.org/W1965334496","https://openalex.org/W1967722500","https://openalex.org/W1968637943","https://openalex.org/W1969130118","https://openalex.org/W1969612147","https://openalex.org/W1978342290","https://openalex.org/W1983404085","https://openalex.org/W1983627169","https://openalex.org/W1985881933","https://openalex.org/W1988171149","https://openalex.org/W1994306318","https://openalex.org/W2001619275","https://openalex.org/W2007065735","https://openalex.org/W2007446108","https://openalex.org/W2008215214","https://openalex.org/W2008374886","https://openalex.org/W2010504165","https://openalex.org/W2011606970","https://openalex.org/W2015488490","https://openalex.org/W2015804212","https://openalex.org/W2016154588","https://openalex.org/W2016652516","https://openalex.org/W2016940189","https://openalex.org/W2022313790","https://openalex.org/W2022378061","https://openalex.org/W2023752814","https://openalex.org/W2024545561","https://openalex.org/W2025429574","https://openalex.org/W2026920124","https://openalex.org/W2033853536","https://openalex.org/W2037139658","https://openalex.org/W2037973675","https://openalex.org/W2038299708","https://openalex.org/W2039738625","https://openalex.org/W2044558761","https://openalex.org/W2051967152","https://openalex.org/W2056414462","https://openalex.org/W2056548197","https://openalex.org/W2057137756","https://openalex.org/W2058592457","https://openalex.org/W2060402638","https://openalex.org/W2061688783","https://openalex.org/W2061691777","https://openalex.org/W2062044685","https://openalex.org/W2062186332","https://openalex.org/W2064596734","https://openalex.org/W2065964876","https://openalex.org/W2071973373","https://openalex.org/W2074093675","https://openalex.org/W2075154388","https://openalex.org/W2075624792","https://openalex.org/W2076472126","https://openalex.org/W2078681603","https://openalex.org/W2080639248","https://openalex.org/W2081822887","https://openalex.org/W2083623577","https://openalex.org/W2086759170","https://openalex.org/W2086816629","https://openalex.org/W2087174765","https://openalex.org/W2089912569","https://openalex.org/W2090116461","https://openalex.org/W2091486815","https://openalex.org/W2092484618","https://openalex.org/W2095043290","https://openalex.org/W2097643979","https://openalex.org/W2099700185","https://openalex.org/W2100216728","https://openalex.org/W2100606390","https://openalex.org/W2106257034","https://openalex.org/W2106607972","https://openalex.org/W2106915249","https://openalex.org/W2112805640","https://openalex.org/W2113211592","https://openalex.org/W2115041711","https://openalex.org/W2120520596","https://openalex.org/W2121060688","https://openalex.org/W2121237571","https://openalex.org/W2122857952","https://openalex.org/W2124815249","https://openalex.org/W2129874579","https://openalex.org/W2137471600","https://openalex.org/W2139230578","https://openalex.org/W2139674907","https://openalex.org/W2143086898","https://openalex.org/W2147434999","https://openalex.org/W2147612834","https://openalex.org/W2151414518","https://openalex.org/W2156828335","https://openalex.org/W2157050914","https://openalex.org/W2161794953","https://openalex.org/W2162534784","https://openalex.org/W2164205049","https://openalex.org/W2165223719","https://openalex.org/W2169205273","https://openalex.org/W2203342607","https://openalex.org/W2241109898","https://openalex.org/W2396372558","https://openalex.org/W2404476850","https://openalex.org/W2418722848","https://openalex.org/W2418985423","https://openalex.org/W2482612809","https://openalex.org/W2565783397","https://openalex.org/W4246109793","https://openalex.org/W4298329490","https://openalex.org/W4406059090","https://openalex.org/W6604112950"],"related_works":["https://openalex.org/W2133671844","https://openalex.org/W4246109793","https://openalex.org/W2121060688","https://openalex.org/W2064596734","https://openalex.org/W41628817","https://openalex.org/W2060402638","https://openalex.org/W2044558761","https://openalex.org/W2113211592","https://openalex.org/W2050546106"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1520508152","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
